Sariguna Primatirta PT (CLEO)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 408.00 |
|---|---|
| 52-week range | 320.00 – 550.00 |
| Return, 1 month / 3 months | −1.9% / +7.4% |
| Return, 1 year / 3 years | −22.5% / +29.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 34.7% |
| Worst drawdown (1 year) | -40.4% |
| Average daily value traded | 5,484.28M IDR |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sariguna Primatirta PT is an Indonesian bottled water company based in East Java. It produces and sells drinking water in packaged forms, including bottled and cup-packed water, mainly under the Cleo brand. Its customers are everyday consumers, shops, restaurants and other outlets across Indonesia that stock packaged drinks. The company also offers water dispensers and related drinking water products, serving households and businesses that need clean drinking water delivered in bulk containers.
The shares are listed on the Jakarta Exchange in Indonesia under the code CLEO, and the price on this page is in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sariguna Primatirta PT (CLEO) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 408.00 on 23 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 124 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 22.5% and over the last three months it rose 7.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 2.2% | ||
| From 52-week high | -24.4% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.4% | ||
| 6-month return | 3.7% | ||
| 12-month return, skipping the last month | -21.0% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.4% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 5,484.28M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | −1.9% |
| 3 months | +7.4% |
| 6 months | +3.7% |
| 1 year | −22.5% |
| 3 years | +29.3% |
| 5 years | +75.0% |
Signals
| 50-day / 200-day average | 412.72 / 399.26 |
|---|---|
| Golden / death cross (60 days) | Golden, 14 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 19.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jul 2026 | IDR 2.5000 |
| 10 Jun 2025 | IDR 5.0000 |
| 10 Jun 2024 | IDR 5.0500 |
| 13 Jun 2023 | IDR 1.6500 |
| 10 Jun 2022 | IDR 1.0000 |
| 3 Dec 2021 | IDR 2.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.